Material
-
WAPPS-Hemo, English
Information about WAPPS-Hemo, an online tool facilitating individualized dosingArtnr: 180212 -
Vårdprogram Hemostas vid allvarlig blödning 2020
Artnr: 303538 -
Thieme Idelvion Drug report + Therapy Card
Artnr: Idel170331 -
Syst. overview of the first pasteurised VWF/FVIII medicinal product, Haemate P/ Humate -P
Artnr: 110150 -
Safety, efficacy and pharmacokinetics of rVIII-SingleChain in children with severe hemophilia A, English
Results of a multicenter clinical trialArtnr: 110707 -
Safety of Factor XIII Concentrate, English
Artnr: 190510 -
PROLONG-9FP
Clinical development program-phase I results of recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP)Artnr: 110620 -
Population pharmacokinetics
Population pharmacokinetics of recombinant coagulation factor VIII-SingleChain in patients with severe hemophilia AArtnr: 110715 -
Physicochemical characterisation of rVIII-SingleChain, English
A novel recombinant single-chain factor VIIIArtnr: 110634 -
Patientinformation Svensk
Artnr: 302102 -
Mix2Vial Demokit
Artnr: 304113 -
Mahlangu et al.: Efficacy and safety of rVIII-SingleChain, English
Artnr: 110667 -
Lonoctocog Alfa, English
A Review in Haemophilia AArtnr: 110728 -
Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children
Artnr: 110673 -
Long-acting recombinant coagulation factor IX albumin fusion protien (rlX-FP)
Artnr: Idel110656 -
Life in the shadow of a dominant partner, English
The FVIII-VWF association and its clinical implications for hemophilia AArtnr: 110741 -
International comparative field study
International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratoriesArtnr: 110743 -
Efficacy and safety of long&-acting recombinant fusion protein linking factor IX with albumin in hemophilia B patients undergoing surgery, English
Artnr: 110666 -
Comparative pharmacokinetics
Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate) in patients with severe haemophilia AArtnr: 110677 -
Coagulation Factor IX (Recombinant), Albumin Fusion Protein (Albutrepenonacog Alfa, Idelvion ®)
A Review of Its Use in Haemophilia B.Artnr: 110704
SWE-GEN-0048
